Kampo medicine in the management of menopausal symptoms: A narrative review of therapeutic potential

Liu YZ, Kobayashi S, Wang L, Ren YM, Song PP

Drug Discov Ther. 2025; 19(3):136-147.

DOI: 10.5582/ddt.2025.01039

Quercetin as a multifaceted therapeutic agent in recurrent pregnancy loss: Mechanisms and clinical perspectives

Qi Q, Zhou J, Wang J, Zhou YY, Sun HM, Wang L

Drug Discov Ther. 2025; 19(3):148-159.

DOI: 10.5582/ddt.2025.01059

Abortion adverse events associated with adalimumab, etanercept, ustekinumab, and dupilumab during pregnancy: A pharmacovigilance study based on FDA adverse event reporting system

Liu Q, Wang Y, Hu PW, He PZ

Drug Discov Ther. 2025; 19(3):160-173.

DOI: 10.5582/ddt.2025.01043

Immune modulation and improved systemic performance of phosphate-functionalized nanogels for antifungal therapy

Vogel T, Yu Y, Keller T, Miyashita A, Munakata L, Suzuki R, Beilhack A, Groll J, Sekimizu K, Albrecht K

Drug Discov Ther. 2025; 19(3):174-183.

DOI: 10.5582/ddt.2025.01041

Opsin 3-mediated regulation of blue light-induced β-hexosaminidase release from mast cells

Yamamoto H, Kiryu M, Sawaguchi Y, Yamada T

Drug Discov Ther. 2025; 19(3):184-188.

DOI: 10.5582/ddt.2025.01035

Discovery of SARS-CoV-2 papain-like protease inhibitors through machine learning and molecular simulation approaches

Li L, Li J, Zhang Q, Huang Y, Bao Y, Tang X

Drug Discov Ther. 2025; 19(3):189-199.

DOI: 10.5582/ddt.2025.01034

Trpa1 knockout favors colon tumorigenesis in dextran sulfate sodium (DSS)-induced colitis mice

Dou FZ, Hu SS, Lu DR, Gao JJ

Drug Discov Ther. 2025; 19(3):200-207.

DOI: 10.5582/ddt.2025.01022

The pTau217/Aβ_1-42 plasma ratio: The first FDA-cleared blood biomarker test for diagnosis of Alzheimer's disease

Hu SS, Yu HZ, Gao JJ

Drug Discov Ther. 2025; 19(3):208-209.

DOI: 10.5582/ddt.2025.01055

Acoltremon: The first TRPM8 agonist approved for the treatment of dry eye disease

Zhou Y, Zhang WZ, Sun FS

Drug Discov Ther. 2025; 19(3):210-211.

DOI: 10.5582/ddt.2025.01048

Primary cutaneous lymphoma is a microsatellite stable tumor: An analysis of microsatellite instability

Maeda-Otsuka S, Mijiddorj MT, Kajihara I, Sawamura S, Makino K, Masuguchi S, Fukushima S

Drug Discov Ther. 2025; 19(3):212-213.

DOI: 10.5582/ddt.2025.01042